Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Cipla
McKesson
Julphar
Chinese Patent Office
Dow
McKinsey
Moodys
Deloitte

Generated: February 19, 2018

DrugPatentWatch Database Preview

CHILDREN'S ZYRTEC HIVES RELIEF Drug Profile

« Back to Dashboard

Which patents cover Children's Zyrtec Hives Relief, and when can generic versions of Children's Zyrtec Hives Relief launch?

Children's Zyrtec Hives Relief is a drug marketed by J And J Consumer Inc and is included in two NDAs. There is one patent protecting this drug.

This drug has twenty-five patent family members in twenty countries.

The generic ingredient in CHILDREN'S ZYRTEC HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for CHILDREN'S ZYRTEC HIVES RELIEF
Drug patent expirations by year for CHILDREN'S ZYRTEC HIVES RELIEF
Medical Subject Heading (MeSH) Categories for CHILDREN'S ZYRTEC HIVES RELIEF

US Patents and Regulatory Information for CHILDREN'S ZYRTEC HIVES RELIEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc CHILDREN'S ZYRTEC HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 022155-001 Nov 16, 2007 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
J And J Consumer Inc CHILDREN'S ZYRTEC HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-005 Nov 16, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
J And J Consumer Inc CHILDREN'S ZYRTEC HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-006 Nov 16, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for CHILDREN'S ZYRTEC HIVES RELIEF

Supplementary Protection Certificates for CHILDREN'S ZYRTEC HIVES RELIEF

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
01C/045 Belgium ➤ Sign Up PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
00085 Netherlands ➤ Sign Up PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Healthtrust
Chinese Patent Office
Chubb
Accenture
Cerilliant
Daiichi Sankyo
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot